These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 37097217

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. A study of genotyping for management of human papillomavirus-positive, cytology-negative cervical screening results.
    Schiffman M, Burk RD, Boyle S, Raine-Bennett T, Katki HA, Gage JC, Wentzensen N, Kornegay JR, Aldrich C, Tam T, Erlich H, Apple R, Befano B, Castle PE.
    J Clin Microbiol; 2015 Jan; 53(1):52-9. PubMed ID: 25339396
    [Abstract] [Full Text] [Related]

  • 23. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].
    Luo HX, Du H, Liu ZH, Zhang LJ, Wang C, Wu RF.
    Zhonghua Zhong Liu Za Zhi; 2018 Mar 23; 40(3):232-238. PubMed ID: 29575846
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Human papillomavirus test with cytology triage in organized screening for cervical cancer.
    Veijalainen O, Kares S, Kujala P, Tirkkonen M, Vuento R, Kholová I, Luukkaala T, Osuala V, Mäenpää J.
    Acta Obstet Gynecol Scand; 2016 Nov 23; 95(11):1220-1227. PubMed ID: 27591407
    [Abstract] [Full Text] [Related]

  • 27. [Risk stratification of type-specific human papillomavirus for cervical precancers: evidence from a cross-sectional study in Shenzhen].
    Liu ZH, Lin W, Wang YY, Wu B, Yuan SX, Yao JL, Zhao XS, Chen B, Qiao YL, Zhao FH, Chen W, Hu SY.
    Zhonghua Zhong Liu Za Zhi; 2018 Oct 23; 40(10):757-763. PubMed ID: 30392340
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Diagnostic accuracy of high-risk HPV DNA genotyping for primary cervical cancer screening and triage of HPV-positive women, compared to cytology: preliminary results of the PIPAVIR study.
    Chatzistamatiou K, Moysiadis T, Angelis E, Kaufmann A, Skenderi A, Jansen-Duerr P, Lekka I, Kilintzis V, Angelidou S, Katsiki E, Hagemann I, Tsertanidou A, Koch I, Boecher O, Soutschek E, Maglaveras N, Agorastos T.
    Arch Gynecol Obstet; 2017 May 23; 295(5):1247-1257. PubMed ID: 28337594
    [Abstract] [Full Text] [Related]

  • 30. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
    Gilham C, Sargent A, Kitchener HC, Peto J.
    Health Technol Assess; 2019 Jun 23; 23(28):1-44. PubMed ID: 31219027
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
    Leinonen M, Nieminen P, Kotaniemi-Talonen L, Malila N, Tarkkanen J, Laurila P, Anttila A.
    J Natl Cancer Inst; 2009 Dec 02; 101(23):1612-23. PubMed ID: 19903804
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study.
    Zorzi M, Del Mistro A, Farruggio A, de'Bartolomeis L, Frayle-Salamanca H, Baboci L, Bertazzo A, Cocco P, Fedato C, Gennaro M, Marchi N, Penon MG, Cogo C, Ferro A.
    BJOG; 2013 Sep 02; 120(10):1260-7; discussion 1267-8. PubMed ID: 23786222
    [Abstract] [Full Text] [Related]

  • 37. Utility of Human Papillomavirus Genotyping for Triage of Patients with Atypical Squamous Cells of Undetermined Significance by Cervical Cytology.
    Lee B, Suh DH, Kim K, No JH, Kim YB.
    Anticancer Res; 2015 Jul 02; 35(7):4197-202. PubMed ID: 26124378
    [Abstract] [Full Text] [Related]

  • 38. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
    Canfell K, Caruana M, Gebski V, Darlington-Brown J, Heley S, Brotherton J, Gertig D, Jennett CJ, Farnsworth A, Tan J, Wrede CD, Castle PE, Saville M.
    PLoS Med; 2017 Sep 02; 14(9):e1002388. PubMed ID: 28926579
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.